Virax Biolabs Presents Data on T-Cell Dysfunction in Post-acute Infection Syndromes at the 19th World Immune Regulation Meeting

Core Insights - Virax Biolabs Group Limited presented data on T-Cell dysfunction in post-acute infection syndromes (PAIS) at the World Immune Regulation Meeting in Davos, Switzerland [1] - The data indicates that chronic infections can lead to T-Cell exhaustion, which is associated with reduced immune functionality and impaired cytokine production [2][3] - The company is conducting clinical validation studies to assess the link between T-Cell dysfunction and symptoms such as chronic fatigue and cognitive impairment [3] Company Overview - Virax Biolabs is focused on the detection of immune responses and diagnosis of viral diseases, developing T-Cell-based test technologies for immunology profiling [4] - The company aims to address post-viral syndromes like Long COVID and other chronic conditions linked to immune dysregulation through its diagnostic technologies [4]